Insider Transactions in Q4 2021 at 2seventy Bio, Inc. (TSVT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2021
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
257
-0.44%
|
$7,967
$31.06 P/Share
|
|
Nov 11
2021
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
56,226
+37.39%
|
-
|
|
Nov 11
2021
|
Sarah Js Glickman |
BUY
Grant, award, or other acquisition
|
Direct |
3,002
+50.0%
|
-
|
|
Nov 11
2021
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,009
+38.14%
|
-
|
|
Nov 11
2021
|
Nicola Heffron Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,687
+36.76%
|
-
|
|
Nov 11
2021
|
Ramy Ibrahim |
BUY
Grant, award, or other acquisition
|
Direct |
3,450
+43.36%
|
-
|
|
Nov 11
2021
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
109,616
+35.22%
|
-
|
|
Nov 11
2021
|
Daniel Lynch |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+33.95%
|
-
|
|
Nov 11
2021
|
Marcela V. Maus |
BUY
Grant, award, or other acquisition
|
Direct |
3,002
+50.0%
|
-
|
|
Nov 11
2021
|
William R. Sellers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,221
+44.24%
|
-
|
|
Nov 11
2021
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
2,494
+45.38%
|
-
|
|
Nov 04
2021
|
Bluebird Bio, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
23,369,088
-100.0%
|
-
|
|
Nov 03
2021
|
Bluebird Bio, Inc. > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
23,368,988
+50.0%
|
-
|